NM_198402.5:c.58G>T

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The NM_198402.5(HACD2):​c.58G>T​(p.Ala20Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000572 in 1,485,962 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000020 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000061 ( 1 hom. )

Consequence

HACD2
NM_198402.5 missense

Scores

1
1
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.927

Publications

0 publications found
Variant links:
Genes affected
HACD2 (HGNC:9640): (3-hydroxyacyl-CoA dehydratase 2) The protein encoded by this gene can catalyze the third step (dehydration) in the conversion of long chain fatty acids to very long chain fatty acids. The encoded protein localizes to the endoplasmic reticulum membrane. [provided by RefSeq, Jul 2016]
MYLK-AS1 (HGNC:42440): (MYLK antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.012791753).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HACD2NM_198402.5 linkc.58G>T p.Ala20Ser missense_variant Exon 1 of 7 ENST00000383657.10 NP_940684.1 Q6Y1H2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HACD2ENST00000383657.10 linkc.58G>T p.Ala20Ser missense_variant Exon 1 of 7 1 NM_198402.5 ENSP00000373153.5 Q6Y1H2

Frequencies

GnomAD3 genomes
AF:
0.0000198
AC:
3
AN:
151760
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000642
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000226
AC:
27
AN:
119438
AF XY:
0.000243
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000615
AC:
82
AN:
1334202
Hom.:
1
Cov.:
32
AF XY:
0.0000866
AC XY:
57
AN XY:
658046
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
28132
American (AMR)
AF:
0.00
AC:
0
AN:
33054
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
22472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
31198
South Asian (SAS)
AF:
0.00101
AC:
78
AN:
76898
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40800
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4904
European-Non Finnish (NFE)
AF:
9.59e-7
AC:
1
AN:
1042576
Other (OTH)
AF:
0.0000554
AC:
3
AN:
54168
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
5
10
14
19
24
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000198
AC:
3
AN:
151760
Hom.:
0
Cov.:
33
AF XY:
0.0000405
AC XY:
3
AN XY:
74096
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41448
American (AMR)
AF:
0.00
AC:
0
AN:
15228
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5132
South Asian (SAS)
AF:
0.000642
AC:
3
AN:
4670
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10590
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67904
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
ExAC
AF:
0.000143
AC:
13

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Oct 04, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.58G>T (p.A20S) alteration is located in exon 1 (coding exon 1) of the HACD2 gene. This alteration results from a G to T substitution at nucleotide position 58, causing the alanine (A) at amino acid position 20 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.084
BayesDel_addAF
Benign
-0.49
T
BayesDel_noAF
Benign
-0.52
CADD
Benign
11
DANN
Benign
0.83
DEOGEN2
Benign
0.0062
T
Eigen
Benign
-1.0
Eigen_PC
Benign
-0.95
FATHMM_MKL
Benign
0.0089
N
LIST_S2
Benign
0.38
T
M_CAP
Uncertain
0.24
D
MetaRNN
Benign
0.013
T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
0.0
N
PhyloP100
0.93
PrimateAI
Pathogenic
0.82
D
PROVEAN
Benign
-0.63
N
REVEL
Benign
0.021
Sift
Benign
0.30
T
Sift4G
Benign
0.48
T
Polyphen
0.0
B
Vest4
0.11
MutPred
0.30
Gain of glycosylation at A20 (P = 4e-04);
MVP
0.043
MPC
0.60
ClinPred
0.083
T
GERP RS
0.38
PromoterAI
-0.053
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.11
gMVP
0.38
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs770404869; hg19: chr3-123303817; API